L-ergothioneine

L-ergothioneine is a naturally occurring thione-form amino acid derivative synthesized exclusively by fungi and certain bacteria, absorbed into human tissues via the OCTN1 transporter. It functions as a highly stable antioxidant by scavenging reactive oxygen species and chelating metal ions, protecting cells from oxidative and inflammatory damage.

Origin & History

L-Ergothioneine is a sulfur-containing amino acid derived from L-histidine, synthesized by certain bacteria and fungi. Humans acquire it through diet as it cannot be synthesized endogenously.

Historical & Cultural Context

There is no historical or traditional use mentioned in the research for L-ergothioneine.

Health Benefits

• Acts as a stable antioxidant, protecting against oxidative stress[3]. • Detoxifies reactive oxygen species (ROS) and elevates intracellular thiol levels[3]. • Protects the liver and kidneys from oxidative damage[3]. • Reduces expression of MMP1 in UV-irradiated human dermal fibroblasts, potentially providing anti-aging skin effects[3]. • Conserves levels of glutathione and α-tocopherol[3].

How It Works

L-ergothioneine exists predominantly in its thione tautomeric form, which confers exceptional radical-scavenging stability compared to conventional thiols. It is actively concentrated in tissues via the organic cation transporter OCTN1 (SLC22A4), accumulating in mitochondria, erythrocytes, and the liver where oxidative stress is highest. It chelates divalent metal ions such as Cu²⁺ and Fe²⁺, inhibiting Fenton-type reactions, and suppresses the NF-κB pathway to reduce downstream MMP1 expression and pro-inflammatory cytokine production.

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses are available for L-ergothioneine. The research is primarily based on biochemical and in-vitro studies.

Clinical Summary

Preclinical studies in rodent models demonstrate hepatoprotective and nephroprotective effects, with measurable reductions in lipid peroxidation markers such as MDA following ergothioneine supplementation. In vitro studies using UV-irradiated human dermal fibroblasts show significant downregulation of MMP1 expression, suggesting anti-photoaging potential. Human epidemiological data correlate low plasma ergothioneine levels with increased risk of cardiovascular disease and cognitive decline, though large-scale randomized controlled trials in humans remain limited. Early-phase human pharmacokinetic studies confirm oral bioavailability and tissue accumulation, but clinical efficacy trials with quantified outcomes are still emerging.

Nutritional Profile

L-ergothioneine is a naturally occurring amino acid derivative (thiohistidine betaine) and specialized bioactive compound, not a significant source of macronutrients or conventional micronutrients. Molecular weight: 229.3 g/mol. It contains a unique sulfur-containing imidazole ring structure with a thione tautomeric form that confers exceptional antioxidant stability. Found in highest concentrations in mushrooms (e.g., king oyster/Pleurotus eryngii: ~40–50 mg/100g dry weight; shiitake: ~11–13 mg/100g dry weight; white button: ~0.4–2.0 mg/100g dry weight), black beans (~0.1 mg/100g), oat bran (~0.18 mg/100g), and organ meats such as liver and kidney (~0.2–1.5 mg/100g wet weight). As a pure compound used in formulations or supplements, it is typically dosed at 5–30 mg/day. Bioavailability is notably high in humans due to a dedicated transporter protein, OCTN1 (SLC22A4), which actively shuttles ergothioneine into cells and tissues, resulting in preferential accumulation in mitochondria, erythrocytes, liver, kidney, bone marrow, and the lens of the eye. Plasma concentrations in humans typically range from 1–4 µmol/L under normal dietary intake. It is not synthesized endogenously in humans and is therefore considered a 'longevity vitamin' candidate. Contains no significant caloric value, fiber, or fat in its isolated form.

Preparation & Dosage

No clinically studied dosage ranges or forms are available for L-ergothioneine. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Glutathione, Alpha-lipoic acid, CoQ10, Resveratrol

Safety & Interactions

L-ergothioneine has a well-established safety profile with no significant adverse effects reported in human studies at supplemental doses typically ranging from 5 to 30 mg per day. No confirmed drug interactions have been documented, though theoretical caution is warranted with medications transported by OCTN1, such as certain cationic drugs including verapamil and quinidine, due to shared transporter competition. Pregnant and breastfeeding individuals lack sufficient clinical trial data to confirm safety, and conservative avoidance or physician consultation is recommended. It is generally recognized as safe at dietary levels obtained through mushroom-rich diets.